Used primarily in pharmaceutical research as a key intermediate in the synthesis of targeted protein degraders, especially cereblon E3 ligase modulators. Its structure enables selective binding to cereblon, making it valuable in developing PROTACs (proteolysis-targeting chimeras) for cancer therapy and inflammatory diseases. The bromo and fluoro substituents allow further functionalization via cross-coupling reactions, facilitating the creation of diverse compound libraries for drug discovery. Also employed in studies involving molecular glues and ubiquitin-proteasome system modulation due to its ability to induce degradation of specific disease-related proteins.